SI0785950T1 - Keratinocyte growth factor analogs - Google Patents
Keratinocyte growth factor analogsInfo
- Publication number
- SI0785950T1 SI0785950T1 SI9530653T SI9530653T SI0785950T1 SI 0785950 T1 SI0785950 T1 SI 0785950T1 SI 9530653 T SI9530653 T SI 9530653T SI 9530653 T SI9530653 T SI 9530653T SI 0785950 T1 SI0785950 T1 SI 0785950T1
- Authority
- SI
- Slovenia
- Prior art keywords
- growth factor
- keratinocyte growth
- factor analogs
- analogs
- kgf
- Prior art date
Links
- 102000003972 Fibroblast growth factor 7 Human genes 0.000 title 1
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 title 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Genetics & Genomics (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32333794A | 1994-10-13 | 1994-10-13 | |
US48782595A | 1995-06-07 | 1995-06-07 | |
EP95938216A EP0785950B1 (en) | 1994-10-13 | 1995-10-12 | Keratinocyte growth factor analogs |
PCT/US1995/013075 WO1996011951A2 (en) | 1994-10-13 | 1995-10-12 | Keratinocyte growth factor analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
SI0785950T1 true SI0785950T1 (en) | 2003-08-31 |
Family
ID=26983900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9530653T SI0785950T1 (en) | 1994-10-13 | 1995-10-12 | Keratinocyte growth factor analogs |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0785950B1 (ja) |
JP (2) | JP4422210B2 (ja) |
AT (1) | ATE237634T1 (ja) |
AU (1) | AU3893195A (ja) |
CA (1) | CA2202390C (ja) |
DE (1) | DE69530404T2 (ja) |
DK (1) | DK0785950T3 (ja) |
ES (1) | ES2196088T3 (ja) |
HU (1) | HUT78069A (ja) |
MX (1) | MX9702665A (ja) |
NO (1) | NO971621L (ja) |
PT (1) | PT785950E (ja) |
SI (1) | SI0785950T1 (ja) |
WO (1) | WO1996011951A2 (ja) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9407035A (pt) | 1993-06-29 | 1996-03-12 | Chiron Corp | Fragmento de fator de crescimento de queratinócitos conjugado composição terapêutica molécula de DNA vetor de expressão célula hospedeira processo para produzir fragmento de fator de crescimento de queratinócitos processo para cicatrização de ferimento e processo de tratamento de doença hiperproliferativa da epiderme |
US7084119B2 (en) | 1993-06-29 | 2006-08-01 | Chiron Corporation | Truncated keratinocyte growth factor (KGF) having increased biological activity |
IL147575A (en) * | 1994-10-13 | 2004-05-12 | Amgen Inc | Method for purifying keratinocyte growth factors |
US6077692A (en) * | 1995-02-14 | 2000-06-20 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 |
US6693077B1 (en) | 1995-02-14 | 2004-02-17 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 |
US7232667B2 (en) | 1995-02-14 | 2007-06-19 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 polynucleotides |
US6211150B1 (en) * | 1996-07-19 | 2001-04-03 | Amgen Inc. | Analogs of cationic proteins |
SI0935652T1 (en) * | 1996-10-15 | 2004-06-30 | Amgen Inc. | Keratinocyte growth factor-2 products |
DE69728415T2 (de) * | 1996-10-15 | 2004-08-12 | Amgen Inc., Thousand Oaks | Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2) |
US6743422B1 (en) | 1996-10-15 | 2004-06-01 | Amgen, Inc. | Keratinocyte growth factor-2 products |
CA2316015A1 (en) | 1997-12-22 | 1999-07-01 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 formulations |
US6869927B1 (en) | 1997-12-22 | 2005-03-22 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 formulations |
US6248725B1 (en) | 1999-02-23 | 2001-06-19 | Amgen, Inc. | Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction |
CA2457781A1 (en) | 2001-08-21 | 2003-02-27 | Chiron Corporation | Kgf polypeptide compositions |
AU2005317166B2 (en) | 2004-12-15 | 2009-09-10 | Biovitrum Ab (Publ) | Therapeutic formulations of keratinocyte growth factor |
KR20230127721A (ko) * | 2022-02-25 | 2023-09-01 | 한국해양과학기술원 | 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG46699A1 (en) * | 1989-01-31 | 1998-02-20 | Jeffrey S Rubin | DNA encoding a growth factor specific for epithelial cells |
ATE299181T1 (de) * | 1993-09-24 | 2005-07-15 | Wyeth Corp | Strukturelle analoge oberflächenschlaufen der fibroblasten-wachstumsfaktoren |
-
1995
- 1995-10-12 EP EP95938216A patent/EP0785950B1/en not_active Expired - Lifetime
- 1995-10-12 DK DK95938216T patent/DK0785950T3/da active
- 1995-10-12 WO PCT/US1995/013075 patent/WO1996011951A2/en active IP Right Grant
- 1995-10-12 CA CA002202390A patent/CA2202390C/en not_active Expired - Fee Related
- 1995-10-12 MX MX9702665A patent/MX9702665A/es not_active IP Right Cessation
- 1995-10-12 SI SI9530653T patent/SI0785950T1/xx unknown
- 1995-10-12 AU AU38931/95A patent/AU3893195A/en not_active Abandoned
- 1995-10-12 ES ES95938216T patent/ES2196088T3/es not_active Expired - Lifetime
- 1995-10-12 HU HU9901325A patent/HUT78069A/hu unknown
- 1995-10-12 AT AT95938216T patent/ATE237634T1/de active
- 1995-10-12 DE DE69530404T patent/DE69530404T2/de not_active Expired - Lifetime
- 1995-10-12 PT PT95938216T patent/PT785950E/pt unknown
- 1995-10-12 JP JP51337096A patent/JP4422210B2/ja not_active Expired - Fee Related
-
1997
- 1997-04-09 NO NO971621A patent/NO971621L/no unknown
-
2006
- 2006-09-01 JP JP2006237876A patent/JP2007020575A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PT785950E (pt) | 2003-09-30 |
JP4422210B2 (ja) | 2010-02-24 |
NO971621L (no) | 1997-06-12 |
AU3893195A (en) | 1996-05-06 |
DE69530404T2 (de) | 2003-11-13 |
ES2196088T3 (es) | 2003-12-16 |
WO1996011951A3 (en) | 1996-12-12 |
JP2000511762A (ja) | 2000-09-12 |
MX9702665A (es) | 1997-07-31 |
HUT78069A (hu) | 1999-08-30 |
CA2202390C (en) | 2005-05-17 |
DK0785950T3 (da) | 2003-07-28 |
ATE237634T1 (de) | 2003-05-15 |
JP2007020575A (ja) | 2007-02-01 |
WO1996011951A2 (en) | 1996-04-25 |
DE69530404D1 (de) | 2003-05-22 |
EP0785950B1 (en) | 2003-04-16 |
NO971621D0 (no) | 1997-04-09 |
EP0785950A2 (en) | 1997-07-30 |
CA2202390A1 (en) | 1996-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI0785950T1 (en) | Keratinocyte growth factor analogs | |
BG101408A (en) | Analogs of keratinocyte growth factor | |
AU6286986A (en) | Peptide analogues of mammalian insulin-like growth factor-1 | |
AU7550098A (en) | System for expressing hyperthermostable protein | |
MY123740A (en) | Il-13 receptor polypeptide | |
ES2000216A6 (es) | Procedimiento para preparar un polipeptido purificado que tiene propiedades inhibidoras de la coagulacion de la sangre. | |
RU94045952A (ru) | Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена | |
EP0374044A3 (en) | Tgf - beta 1 / beta 2 : a novel chimeric transforming growth factor-beta. | |
ES2095255T3 (es) | Analogos de sustitucion de peptidos magainina. | |
HUT76668A (en) | Novel process for the production of biologically active dimeric protein | |
AU3258197A (en) | Peptides | |
CA2201944A1 (en) | Analogs of keratinocyte growth factor having enhanced temperature stability | |
CA2133834A1 (en) | Process for preparing modified proteins | |
EP0330700A4 (en) | Human prourokinase-like polypeptide. | |
EP0249412A3 (en) | C-terminal alpha-amidating enzyme and process for production and use thereof | |
NZ511618A (en) | Kininogen fragment 2 peptides with the formula of at least X-His-Lys-X-Lys-X | |
GR3021408T3 (en) | Cloning of a new member of the fibroblast growth factor (fgf) receptor family | |
DK0828004T3 (da) | Proteindisulfidisomerase-gen afledt af stamme af methylotrof gær | |
EP1295943A4 (en) | POLYPEPTIDES CAPABLE THE POWER TO STIMULATE NEUTROPHILES | |
EP0625580A4 (en) | Novel hirudine variant, process for producing the same, and anticoagulant containing the same as active ingredient. | |
EP1158052A4 (en) | BETA-PRIMEVEROSIDASDE GENE | |
MX9709921A (es) | Alfa-d-galactosidasas de glicina y phaseolus. | |
MX9700656A (es) | Proceso novedoso para la produccion de proteina dimerica biologicamente activa. |